Back to School: How biopharma can reboot drug development. Access exclusive analysis here

KGF: Phase I data; Phase I/II

In a placebo-controlled dose-escalation Phase I trial of KGF administered with

Read the full 112 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE